ArticleJournal of clinical medicine2023

Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis.

Juan F Blanco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.